Memorial Sloan Kettering hematologic oncologist Ariela Noy

Ariela Noy, MD

Lymphoma Specialist

Areas of Expertise

Conditions I Treat

  • Hodgkin lymphoma (Hodgkin’s disease)
  • Non-Hodgkin lymphoma (NHL)
  • Chronic lymphocytic leukemia (CLL)

My Specialties

  • Targeted therapy
View more expertise
Dr. Noy's Office Information
Languages: English, Hebrew, and Spanish
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a board-certified medical oncologist and hematologist who cares for people with Hodgkin and non-Hodgkin lymphoma as well as other cancers of the lymphoid immune system. I have been practicing at MSK since 1997. I am part of a tight-knit team of experts who provide the best care for our patients. 

My determination to help people with blood cancer began when I was in seventh grade and read a biography about a cancer researcher at MSK. Since then, cancer care and research have been my calling. It is my goal to make sure my patients feel well cared for. At MSK, our team of doctors, nurses, social workers, and other staff are strong proponents of patient education. We understand that a cancer diagnosis, whether it is new or cancer that has come back, is scary. We break down the information for our patients so they can get through it one day at a time. We want to take care of the details so our patients can concentrate on healing.

My research interests focus on new treatments, imaging, and quality of life related to lymphoma. In the past few years, many new drugs and therapies have evolved. For example, targeted therapies don’t suppress the immune system nearly as much as older drugs do. That means there is less risk of a patient becoming ill during treatment. In my own work, I evaluated ibrutinibas as a nontraditional and more targeted treatment option for marginal zone lymphoma. This work led to the US Food and Drug Administration’s approval. Other promising advances include sophisticated immune therapies, such as checkpoint inhibitors and chimeric antigen receptor T cell therapy. 

In addition to my clinical and research work at MSK, I have served as Chair of the Lymphoma Working Group for the AIDS Malignancy Consortium, a National Cancer Institute–sponsored research group. I also served on the National Institutes of Health committee that oversaw the national cooperative group lymphoma research agenda, and I have contributed to the national guidelines for lymphoma treatment. 

At MSK, I serve on several committees, including the Quality Assurance Committee for both the Department of Medicine and the Department of Radiology, the Fertility Preservation Committee, and others. I also enjoy my role as a mentor to students from the high school to postgraduate level.

Outside of MSK, I am really blessed to have New York City’s cultural life as my playground. I practice Ashtanga yoga every day, sing in a chamber choir, and paint in my studio. I would like to learn about your interests to better serve your needs. 

What I Do at MSK

I'm a lymphoma specialist, which is a doctor with special training in diagnosing and treating lymphoma (lim-FOH-muh). This cancer starts in the cells of the immune system.

  • Attending Physician
Areas of Expertise

Conditions I Treat

  • Hodgkin lymphoma (Hodgkin’s disease)
  • Non-Hodgkin lymphoma (NHL)
  • Chronic lymphocytic leukemia (CLL)
  • AIDS-associated cancers

My Specialties

  • Targeted therapy
Education & Honors

Education

  • MD, University of Pennsylvania

Residencies

  • Internal Medicine - Columbia Presbyterian Medical Center

Fellowships

  • Hematology/Medical Oncology - Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College

Board Certifications

  • Hematology
  • Medical Oncology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9137— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Dr. Noy sees patients at one location.

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Lymphoma Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Noy’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Ariela Noy discloses the following relationships and financial interests:

  • ADC Therapeutics
    Professional Services and Activities
  • AstraZeneca
    Professional Services and Activities
  • BeiGene, Ltd.
    Professional Services and Activities
  • ClearView Healthcare Partners
    Professional Services and Activities
  • Dava Oncology
    Professional Services and Activities (Uncompensated)
  • Epizyme
    Professional Services and Activities
  • EUSA Pharma
    Professional Services and Activities
  • ExpertConnect
    Professional Services and Activities
  • Gerson Lehrman Group
    Professional Services and Activities
  • Guidepoint Global Advisors
    Professional Services and Activities
  • Health Advances LLC
    Professional Services and Activities
  • Janssen Global Services, LLC
    Professional Services and Activities
  • Medallion Healthcare
    Professional Services and Activities
  • NSCI Group, Inc.
    Professional Services and Activities
  • OncLive
    Professional Services and Activities
  • PER Events, LLC
    Professional Services and Activities
  • Raphael Pharmaceuticals
    Professional Services and Activities
  • Recordati S.p.A.
    Professional Services and Activities
  • Slingshot Insights
    Professional Services and Activities
  • Techspert.io Ltd.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: